Title:
FOOD COMPOSITION, PHARMACEUTICAL COMPOSITION, QUASI DRUG COMPOSITION, COSMETIC COMPOSITION AND SUNDRY ARTICLE FOR PREVENTING OR TREATING COVID-19
Document Type and Number:
WIPO Patent Application WO/2022/054904
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a food composition, a pharmaceutical composition, a quasi drug composition, a cosmetic composition and a sundry article, each being for preventing or treating COVID-19. A food composition, a pharmaceutical composition, a quasi drug composition, a cosmetic composition and a sundry article, each being for preventing or treating COVID-19 and comprising at least one member selected from among a cat's claw extract, a ginger extract, pteropodine and a pharmaceutically acceptable salt thereof, isopteropodine and a pharmaceutically acceptable salt thereof, 6-gingerol and a pharmaceutically acceptable ether thereof and 6-shogaol and a pharmaceutically acceptable ether thereof.
More Like This:
Inventors:
RYO AKIHIDE (JP)
MIYAKAWA KEI (JP)
MORITA TAKESHI (JP)
KUNIYOSHI TOMOKO (JP)
YANG JINWEI (JP)
MIYAKAWA KEI (JP)
MORITA TAKESHI (JP)
KUNIYOSHI TOMOKO (JP)
YANG JINWEI (JP)
Application Number:
PCT/JP2021/033292
Publication Date:
March 17, 2022
Filing Date:
September 10, 2021
Export Citation:
Assignee:
PUBLIC UNIV CORP YOKOHAMA CITY UNIV (JP)
TOKIWA PHYTOCHEMICAL CO LTD (JP)
TOKIWA PHYTOCHEMICAL CO LTD (JP)
International Classes:
A61K36/74; A23L33/105; A61K8/35; A61K8/49; A61K8/9789; A61K8/9794; A61K31/12; A61K31/438; A61K36/9068; A61P31/14; A61Q1/00; A61Q5/02; A61Q5/06; A61Q19/00
Foreign References:
| JP2005343836A | 2005-12-15 |
Other References:
FERREIRA ANDERSON O., POLONINI HUDSON C., DIJKERS ELI C. F.: "Postulated Adjuvant Therapeutic Strategies for COVID-19", JOURNAL OF PERSONALIZED MEDICINE, vol. 10, no. 80, 5 August 2020 (2020-08-05), pages 1 - 33, XP055910588, DOI: 10.3390/jpm10030080
YEPES-PÉREZ ANDRES F., HERRERA-CALDERON OSCAR, SÁNCHEZ-APARICIO JOSÉ-EMILIO, TIESSLER-SALA LAURA, MARÉCHAL JEAN-DIDIER, CARDONA-G : "Investigating Potential Inhibitory Effect of Uncaria tomentosa (Cat’s Claw) against the Main Protease 3CLpro of SARS-CoV-2 by Molecular Modeling", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, OXFORD UNIVERSITY PRESS, US, vol. 2020, 30 September 2020 (2020-09-30), US , pages 1 - 14, XP055910590, ISSN: 1741-427X, DOI: 10.1155/2020/4932572
YEPES-PÉREZ ANDRES F., HERRERA-CALDERON OSCAR, SÁNCHEZ-APARICIO JOSÉ-EMILIO, TIESSLER-SALA LAURA, MARÉCHAL JEAN-DIDIER, CARDONA-G : "Investigating Potential Inhibitory Effect of Uncaria tomentosa (Cat’s Claw) against the Main Protease 3CLpro of SARS-CoV-2 by Molecular Modeling", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, OXFORD UNIVERSITY PRESS, US, vol. 2020, 30 September 2020 (2020-09-30), US , pages 1 - 14, XP055910590, ISSN: 1741-427X, DOI: 10.1155/2020/4932572
Attorney, Agent or Firm:
TAKAHASHI Masayoshi (JP)
Download PDF:
Previous Patent: PRE-FILLED SYRINGE
Next Patent: FRICTION STIR SPOT WELDING METHOD AND WELDED BODY USING SAME
Next Patent: FRICTION STIR SPOT WELDING METHOD AND WELDED BODY USING SAME